FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival

Uncertainty about US FDA's direction under the new president may have spurred staff to ensure views on several issues released before administration changed.

Questions about how US President Donald Trump will shape FDA over the next four years may have driven agency staff to push out an unusually high number of guidances and regulations in recent weeks.

An end-of-administration document dump is typical as outgoing staff rush to complete projects before the new president arrives, but data...